Noninvasive Advanced Cardiovascular Magnetic Resonance-Derived Fontan Hemodynamics Are Associated With Reduced Kidney

Jef Van den Eynde1,2,3,4, Jos J M Westenberg5, Mark G Hazekamp2

  • 1Department of Pediatrics, Division of Pediatric Cardiology Leiden University Medical Center Leiden The Netherlands.

Insights

Kidney dysfunction is common in Fontan circulation patients. Advanced cardiovascular magnetic resonance metrics indicate declining hemodynamics linked to reduced kidney function, suggesting potential targets for improved kidney health.

Area of Science:

  • Cardiology
  • Nephrology
  • Biomedical Engineering

Background:

  • Kidney disease is a critical predictor of mortality in Fontan circulation patients.
  • Clinical and hemodynamic factors contributing to kidney disease in this population are not well-established.

Purpose of the Study:

  • To investigate the prevalence and correlates of kidney dysfunction in adolescents and young adults with Fontan circulation.
  • To explore the association between advanced cardiovascular magnetic resonance (CMR)-derived hemodynamic metrics and kidney function.

Main Methods:

  • 53 ambulatory patients with Fontan circulation underwent advanced CMR, including 4D flow imaging and computational fluid dynamics.
  • Evaluated estimated glomerular filtration rate (eGFR) and albumin-to-creatinine ratio (ACR).
  • Correlated hemodynamic parameters with eGFR and ACR.

Main Results:

  • 20.8% of patients had eGFR <90 mL/min/1.73m² and 39.6% had ACR >3 mg/mmol.
  • Average eGFR decline rate was -1.83 mL/min/1.73m²/year.
  • Lower eGFR was associated with older age, larger body surface area, longer time since Fontan, and lower systemic ventricular ejection fraction.
  • Hemodynamic factors like lower conduit area, higher velocity mismatch, and increased total cavopulmonary connection resistance correlated with lower eGFR.

Conclusions:

  • Kidney dysfunction and albuminuria are prevalent in clinically stable young Fontan patients.
  • CMR-derived hemodynamic metrics are linked to eGFR, offering potential therapeutic targets.
  • Factors driving albuminuria require further investigation.
Abstract

Related Concept Videos

Heart Failure Drugs: Diuretics01:22

Heart Failure Drugs: Diuretics

Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
381
Glomerular Filtration Rate and its Regulation01:28

Glomerular Filtration Rate and its Regulation

The Glomerular Filtration Rate (GFR) is a measure of kidney function, reflecting the volume of filtrate formed per minute in the kidneys. On average, GFR is approximately 125 mL/min in males and 105 mL/min in females. Maintaining a relatively constant GFR is essential for the kidneys to effectively regulate body fluid homeostasis and maintain extracellular stability.
GFR regulation involves two primary intrinsic controls: the myogenic and tubuloglomerular feedback mechanisms.
The myogenic...
2.7K
Factors Affecting Renal Clearance: Renal Impairment01:17

Factors Affecting Renal Clearance: Renal Impairment

Renal dysfunction significantly impairs the renal clearance of drugs, leading to potential complications in drug therapy. Renal failure, which can be caused by various factors, poses a significant challenge in the elimination of drugs from the body.
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
95
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
431